About Accunea
Accunea is a company based in London (United Kingdom) founded in 2017. Accunea has raised $258.15 thousand across 2 funding rounds. The company has 1 employees as of January 31, 2022. Accunea offers products and services including Accunea Monitoring System and AI Trend Analysis Tool. Accunea operates in a competitive market with competitors including MediBeacon, Physidia, FAST BioMedical, Utopic Tech and Prantae Solutions, among others.
- Headquarter London, United Kingdom
- Employees 1 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Accunea Ltd.
- Date of Incorporation 09 Mar, 2017
- Jurisdiction KIDDERMINSTER, WORCESTERSHIRE
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$258.15 K (USD)
in 2 rounds
-
Latest Funding Round
$121.87 K (USD), Seed
Aug 11, 2022
-
Investors
Not available
-
Employee Count
1
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accunea
Accunea offers a comprehensive portfolio of products and services, including Accunea Monitoring System and AI Trend Analysis Tool.
Monitors biomarkers for kidney transplant viability and patient recovery.
Provides AI insights on organ function trends during transplants.
Funding Insights of Accunea
Accunea has successfully raised a total of $258.15K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $121.87 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Accunea
Investment portfolio details for Accunea
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accunea
Detailed financials for Accunea
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accunea Comparisons
Peer comparison for Accunea
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accunea
Accunea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediBeacon, Physidia, FAST BioMedical, Utopic Tech and Prantae Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive optical monitoring of kidney function is developed.
|
|
| Locked | Locked | Locked |
Manufacturer of a hemodialysis monitoring device
|
|
| Locked | Locked | Locked |
Develops fluorescent in-vivo markers for measuring plasma volume and mGFR.
|
|
| Locked | Locked | Locked |
Medical device for kidney diagnosis and management is developed.
|
|
| Locked | Locked | Locked |
Medical imaging and devices for pregnancy monitoring are developed.
|
|
| Locked | Locked | Locked |
Develops innovative devices for bladder monitoring in urology.
|
Detailed competitors of Accunea
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accunea
Complete news archive for Accunea
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accunea
Accunea was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Accunea is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Nick Housby is the current CEO of Accunea.
Accunea is a funded company, having raised a total of $258.15K across 2 funding rounds to date.
As of Jan 31, 2022, the latest employee count at Accunea is 1.
Accunea was founded in 2017 in London, United Kingdom, within the medical device sector. A microsensor array is developed to enable continuous real-time monitoring of kidney function biomarkers. Information on transplant organ performance is provided at the point of care. An AI system is utilized for population-based comparisons and early alerts. Operations focus on innovative assays for established functional markers in renal health.
Accunea's top competitors include MediBeacon, Physidia and Utopic Tech.
Accunea offers Accunea Monitoring System and AI Trend Analysis Tool.